A system for quick analysis of biopharmaceutical products
Official title: A tunable laser scanning system for rapid analysis of biopharmaceutical formulations
Funded at Nirrin Technologies INC · NIH-11007369 · Data updated 2026-11-12
This study is working on a new tool that helps manufacturers keep a close eye on the ingredients in medicines while they're being made, which can lead to safer and more effective drugs for patients like you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nirrin Technologies INC NIH-funded |
| Lab location | 1 site (Billerica, United States) |
| Project start | September 3, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,219,222 |
| NIH project number | 1R44GM156127-01 |
| Project ID | NIH-11007369 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals who rely on biopharmaceuticals for treatment, such as those with chronic diseases requiring protein or peptide therapies.
✕Less likely to help
Patients who are not using biopharmaceuticals or those receiving treatments that do not involve active pharmaceutical ingredients may not benefit from this research.
What this research studies
This research focuses on developing a tunable laser spectrometry system that allows for real-time monitoring of biopharmaceutical formulations during manufacturing. By ensuring precise measurement of active ingredients and excipients, the system aims to prevent costly errors in drug production. Patients can benefit from improved drug safety and efficacy as manufacturers can maintain compliance with FDA standards more effectively. The approach utilizes advanced spectrometry techniques to provide continuous data, which is a significant improvement over traditional end-point analysis methods.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective biopharmaceutical products for patients.
How similar studies have gone: Other research has shown success with real-time monitoring technologies in biomanufacturing, indicating a promising direction for this approach.
Where this research is happening
-
Nirrin Technologies INC
Billerica, United States Active
Researchers
- Principal investigator: Hassell, Bryan — Nirrin Technologies INC
- Study coordinator: Hassell, Bryan
Related research
Other NIH-funded projects on the same topics.
-
High-precision laser spectroscopy integrated into liquid chromatography for faster bioformulation analysis
A new SBIR project aims to combine a laser-based detection technology with standard liquid chromatography to quickly identify and measure all components of biopharmaceutical formulations.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.